State of Alaska Department of Revenue reduced its stake in shares of Genpact Limited (NYSE:G – Free Report) by 0.2% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 336,142 shares of the business services provider’s stock after selling 540 shares during the period. State of Alaska Department of Revenue owned 0.19% of Genpact worth $14,436,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. UMB Bank n.a. increased its stake in shares of Genpact by 55.7% during the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock worth $52,000 after purchasing an additional 433 shares during the last quarter. Venturi Wealth Management LLC increased its position in Genpact by 74.6% during the third quarter. Venturi Wealth Management LLC now owns 2,623 shares of the business services provider’s stock worth $103,000 after buying an additional 1,121 shares during the last quarter. GAMMA Investing LLC raised its holdings in Genpact by 221.3% during the third quarter. GAMMA Investing LLC now owns 3,329 shares of the business services provider’s stock valued at $131,000 after buying an additional 2,293 shares in the last quarter. Versant Capital Management Inc lifted its position in shares of Genpact by 17.0% in the fourth quarter. Versant Capital Management Inc now owns 3,178 shares of the business services provider’s stock worth $136,000 after buying an additional 461 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB boosted its stake in shares of Genpact by 22.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 3,378 shares of the business services provider’s stock worth $145,000 after acquiring an additional 619 shares in the last quarter. 96.03% of the stock is owned by institutional investors and hedge funds.
Genpact Stock Down 0.0 %
NYSE G opened at $49.35 on Thursday. Genpact Limited has a twelve month low of $30.23 and a twelve month high of $49.68. The stock has a market cap of $8.70 billion, a PE ratio of 13.56, a PEG ratio of 1.61 and a beta of 1.20. The firm has a 50-day simple moving average of $44.86 and a 200 day simple moving average of $41.09. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 1.85.
Insider Buying and Selling
In other news, CEO Balkrishan Kalra sold 13,600 shares of the company’s stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $44.60, for a total value of $606,560.00. Following the sale, the chief executive officer now owns 267,404 shares of the company’s stock, valued at approximately $11,926,218.40. This represents a 4.84 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the sale, the senior vice president now owns 151,182 shares of the company’s stock, valued at $6,475,125.06. This trade represents a 7.35 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 35,058 shares of company stock valued at $1,558,675 over the last ninety days. 2.80% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
G has been the topic of several analyst reports. Robert W. Baird increased their price target on Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a report on Friday, November 8th. TD Cowen raised their target price on shares of Genpact from $40.00 to $45.00 and gave the company a “hold” rating in a research note on Friday, November 8th. Jefferies Financial Group upgraded shares of Genpact from a “hold” rating to a “buy” rating and upped their price target for the company from $44.00 to $55.00 in a report on Tuesday, January 21st. Finally, Needham & Company LLC raised their price target on Genpact from $42.00 to $55.00 and gave the company a “buy” rating in a research report on Monday, November 11th. Six investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $44.50.
View Our Latest Stock Analysis on G
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories
- Five stocks we like better than Genpact
- Do ETFs Pay Dividends? What You Need to Know
- Powering Profits: Utility Stocks That Shine in Volatility
- What Are Treasury Bonds?
- Cirrus Logic Upgraded After Q3 Earnings Beat—More Gains Ahead?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- RTX and Lockheed Martin: Buy 1 for Today and 1 for Tomorrow
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.